Ftse Mib
34.011,12
-0,83%
DAX
18.027,63
-0,57%
S&P 500
5.116,17
0,00%
NASDAQ Composite
15.983,08
0,00%
Bitcoin
61.096,86
-4,29%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Natera Inc (NTRA) Natera Inc (NTRA) Notizie

Natera Inc

NTRA
94,04
0,00 (0,00%)
Pre Mercato
Ultimo aggiornamento: 14:32:02
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
22/4/202414:00BWNatera Announces Significant Milestone with 200+..
11/4/202414:00BWNatera Announces Publication of Largest Prospective dd-cfDNA..
08/4/202414:00BWNatera Announces New Data From Two Studies Extending the..
05/4/202413:00BWNatera Announces Positive Surveillance Analysis from the..
01/4/202414:00BWNatera and Alliance for Clinical Trials in Oncology Announce..
18/3/202412:00BWNatera Announces Phase III Randomized CIRCULATE Trial in..
14/3/202413:00BWNew KDIGO Guideline Supports Genetic Testing for the..
12/3/202413:00BWNatera to Present New Data at the 2024 SGO Annual Meeting on..
09/3/202402:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202403:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202403:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202403:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202403:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202403:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202403:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202403:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202414:00BWNatera Announces Commercial Coverage for Prospera™ Kidney..
05/3/202422:34EDGAR2Form 144 - Report of proposed sale of securities
02/3/202402:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/3/202402:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/3/202402:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/3/202402:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/3/202402:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/3/202402:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/3/202402:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202403:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202422:20EDGAR2Form 144 - Report of proposed sale of securities
29/2/202417:35EDGAR2Form 144 - Report of proposed sale of securities
29/2/202414:00BWNatera to Participate in March Investor Conferences
28/2/202422:11EDGAR2Form 8-K - Current report
28/2/202422:05BWNatera Reports Fourth Quarter and Full Year 2023 Financial..
27/2/202422:27EDGAR2Form 144 - Report of proposed sale of securities
27/2/202414:00BWNatera Announces Next Phase of CareDx Patent Infringement..
26/2/202413:00BWMedicare Extends Coverage of Natera’s Signatera™ MRD Test to..
24/2/202403:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202414:00BWNatera Announces Fourth Quarter and Fiscal 2023 Earnings..
09/2/202403:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/2/202403:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202422:59EDGAR2Form 144 - Report of proposed sale of securities
06/2/202422:09EDGAR2Form 144 - Report of proposed sale of securities
05/2/202414:00BWNew Study Validates Signatera™ in Endometrial Cancer
03/2/202403:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202422:47EDGAR2Form 144 - Report of proposed sale of securities
31/1/202403:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202403:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202403:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202403:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202403:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202403:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202403:01EDGAR2Form 3 - Initial statement of beneficial ownership of..
Apertura: Min: Max:
Chiusura: 94,04

La tua Cronologia

NASDAQ
NTRA
Natera
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network